| 摘要 |
<p>The invention concerns the use of nucleic acid sequences coding for oestrogen receptor variants to obtain a medicine. Said medicine is useful for reducing the motility and invasive properties of cancer cells, in particular in the treatment of breast or ovarian cancer.</p> |
